IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Third Rock Ventures, LLC

Q3 2015 Holdings

Filed 2015-11-03 | 5 holdings | $1.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Global Blood Therapeutics inCOM37890U108$622.3K14,760,90058.1%
Sage Therapeutics Inc(SG7)COM78667J108$272.7K6,442,91625.5%
Blueprint Medicines Corp(2L9)COM09627Y109$157.8K7,393,05914.7%
Eleven Biotherapeutics IncCOM286221106$11.7K4,841,5911.1%
Zafgen IncCOM98885E103$6.7K210,3710.6%